drug · protein
lonapegsomatropin LA
Phase 3updated 3mo agoby Ascendis Pharma AS🔗 ChEMBL
Phase 3community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for pituitary dwarfism and growth delay and 3 investigational indications.
targets
Growth hormone receptor
all catalysts(0)
nothing on the calendar yet
Trials studying lonapegsomatropin LA
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that